Phase 3 validation of PAaM for hepatocellular carcinoma risk stratification in cirrhosis.
Fujiwara N, Lopez C, Marsh TL, Raman I, Marquez CA, Paul S, Mishra SK, Kubota N, Katz C, Kanzaki H, Gonzalez M, Quirk L, Deodhar S, Selvakumar P, Raj P, Parikh ND, Roberts LR, Schwartz ME, Nguyen MH, Befeler AS, Page-Lester S, Srivastava S, Feng Z, Reddy KR, Khaderi S, Asrani SK, Kanwal F, El-Serag HB, Marrero JA, Singal AG, Hoshida Y.
Fujiwara N, et al. Among authors: katz c.
Gastroenterology. 2024 Nov 7:S0016-5085(24)05660-9. doi: 10.1053/j.gastro.2024.10.035. Online ahead of print.
Gastroenterology. 2024.
PMID: 39521255